385 results found
We have developed a range of tools and resources to improve the way clinical trials are conducted and overseen in Australia. This page include resources and information for researchers, sponsors, ethics committee members and consumers.
Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
This document clarifies the responsibilities of those involved in clinical trials to monitor and report adverse events and other safety issues. Supplementary guidance on other clinical trial safety monitoring and reporting issues is also available*.
The ICTC Grant Opportunity will provide support for Australian research teams to conduct clinical trial research in collaboration with international counterparts.
This Medical Research Future Fund (MRFF) Coronavirus Research Response Initiative grant opportunity will accelerate research to develop treatments for severe acute respiratory distress in late-stage patients infected with COVID 19 in order to support the response to the COVID-19 outbreak in Australia.
This grant aims to enhance clinical trial activity, treatments, cures, and extend and improve quality of life for young Australians living with brain cancer.
To improve clinical trial start-up times, we developed the Good Practice Process for Site Assessment and Authorisation Phases of Clinical Trial Research Governance (the Good Practice Process).
The Medical Research Future Fund (MRFF) – 2020 International Clinical Trial Collaborations (ICTC) 20.1 Grant Opportunity will support Australian involvement in international collaborative investigator-initiated clinical trials.
The Medical Research Future Fund (MRFF) – 2020 International Clinical Trial Collaborations (ICTC) 20.2 Grant Opportunity will support Australian involvement in international collaborative investigator-initiated clinical trials.
This competitive grant opportunity supports clinical trials that address low survival cancers and diseases, aiming to improve survival rates for Australians with a low survival cancer or other disease.
The ICTC Grant Opportunity will provide support for Australian research teams to conduct clinical trial research in collaboration with international counterparts.
The ICTC Grant Opportunity will provide support for Australian research teams to conduct clinical trial research in collaboration with international counterparts.
The ICTC Grant Opportunity will provide support for Australian research teams to conduct clinical trial research in collaboration with international counterparts.
The Medical Research Future Fund – Emerging Priorities and Consumer Driven Research – 2020 Medicinal Cannabis Clinical Trials Grant Opportunity will support clinical trials that examine the effects of medicinal cannabis for the management of pain, symptoms and side-effects of cancer and cancer treatment in cancer patients.
Applications to this Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) Initiative grant opportunity must propose a clinical trial that addresses a gap in current research and/or knowledge in reproductive cancer. For the purposes of this grant opportunity, reproductive cancers in women are cancers located in the cervix, uterus, vulva, fallopian tubes, endometrium or ovaries, and in men cancers of the testicles and penis are within scope.
Applications to this Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) Initiative grant opportunity must propose a clinical trial that addresses a gap in current research and/or knowledge in neurological disorders, including (but not limited to) Duchenne Muscular Dystrophy (DMD), spinal cord injuries (SCI) and Autism Spectrum Disorders (ASD).
In conjunction with the Australian Clinical Trials Alliance, we developed the clinical trials competencies to be used in the development of detailed curricula and training courses by universities, Colleges and other registered training organisations*.
Applications to this Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) Initiative grant opportunity must propose a clinical trial that addresses a gap in current research and/or knowledge in rare cancers, rare diseases and areas of unmet medical need.
NHMRC is committed to supporting its administering institutions, and the health and medical research sector more broadly, to address the multiple challenges posed by the COVID-19 pandemic